九安医疗拟以3亿元至6亿元回购股份

Core Viewpoint - Company believes that its current stock price does not reflect its true value, prompting a new share buyback plan to enhance market value and protect shareholder interests [1] Group 1: Share Buyback Plan - Company plans to use its own funds and a special loan for share buyback, with a total amount between 300 million yuan (approximately 43 million USD) and 600 million yuan (approximately 86 million USD) [1] - The buyback price will not exceed 53.5 yuan per share [1] - Company has secured a loan commitment of up to 500 million yuan (approximately 72 million USD) from Shanghai Pudong Development Bank, covering up to 90% of the total buyback amount [1] Group 2: Market Context - As of October 13, the company's stock closed at 38.19 yuan per share, with a total market capitalization of 17.75 billion yuan (approximately 2.55 billion USD) [1] - The stock price has fallen below the company's latest net asset value per share, indicating a disconnect between market valuation and intrinsic value [1]